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• Twenty-three children with Alagille's syndrome and end-
stage liver disease,underwent liver transplantation with cy-
closporine and low-dose steroid immunosuppression. Two 
to 9 years (mean, 4.4 years) after surgery, 13 (57%) of the 
children were still alive, with normal liver function. Three 
of the fatalities were due to cardiovascular failure second-
ary to associated cardiopulmonary disease. Mortality was " 
higher among patients who had more severe cardiac disease 
and patients who had previously undergone a Kasai proce-
dure. Although it has a higher than average risk, liver trans-
plantation can be efficacious in patients with Alagille's syn-
drome and end-stage liver disease. 
(Arch Surg. 1993;128:337,339) 
T he Watson-Alagille syndrome, also known as arterio-hepatic dysplasia, is characterized by paucity of 
intrahepatic bile ducts and congenital cardiovascular 
anomalies. I It is inherited by an autosomal-dominant gene 
with reduced penetrance and variable expressivity. Clin-
ical features include retarded growth, dysmorphic facies, 
ocular and cardiovascular anomalies (peripheral pulmo-
nary stenosis mainlv), neonatal cholestasis, mental retar-
dation. skeletal malformations, and xanthomas.:.J Portal 
fibrosis reportedly occurs in 13.7% of the patients. Com-
plications of liver disease are thought to be responsible for 
the deaths of 5% of the patients and constitute an indica-
tion for liver transplantation.H 
In this retrospective study the courses of patients with 
Alagille's syndrome who underwent orthotopic liver 
transplantation with cyclosporine and low-dose steroids at 
the University of Pittsburgh (Pa) were reviewed to identi-
fy factors that may influence the postoperative prognosis. 
PATIENTS AND METHODS 
From March 1980 to October 1989, 475 children underwent 
orthotopic liver transplantation at the Children's Hospital of 
rittsbur~hI In 23 (S'7() of these patients the underlying primary 
disease was Alagille's svndrome. 
All 23 patients underwent a preoperative cardiac evaluation 
consisting ot phYSical and ultrasonographic examination by a pe-
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diatric cardiologist. Right ventricular pressures were estimated 
by Doppler interrogation of the tricuspid valve regurgitation jet. 
Seven patie·nts (30%) underwent cardiac catheterization, On the 
basis of the Doppler examination, cardiopulmonary disease was 
classified as mild if the estimated peak right ventricular pressure 
was lower than half the systemic peak pressure and severe if it 
was three fourths or more the systemic peak pressure, Cases be-
tween mild and severe were classified as moderate, 
If cardiac catheterization was performed. cardiopulmonary 
disease was classified as mild if the mean right atrial pressure was 
o to 5 mm Hg, moderate if 5 through 10 mm Hg, and severe if 
greater than 10 mm Hg, 
• RESULTS 
oft Preoperative Evaluation 
The typical features of the syndrome identified in our 23 
patients are listed in Table 1. During the first 2 months of 
life 21 patients underwent surgical exploration for jaun-
dice, which revealed intrahepatic disease in 11 (52%) of 
these patients. Liver biopsy specimens obtained at the time 
were pathognomonic of arteriohepatic dysplasia in five 
patients (24%), In the remaining 16 patients (76%) the his-
tologic findings were consistent with cholestasis, The 
diagnosis was confirmed with liver histologic features, re-
vealing the paucity of interlobular bile ductules and the 
presence of pulmonary artery stenosis. There was a posi-
tive family history for Alagille's syndrome in 13 patients. 
In five (50%) of the 10 children who died after surgery 
the pathognomonic findings of Alagille's syndrome were 
confirmed at autopsy, Autopsy was not performed in the 
remaining cases. Secondary or less common features of the 
syndrome were also looked for and identified on clinical 
or postmortem examinations. Ten patients underwent a 
Kasai procedure (portoenterostomy), presumably due to 
misdiagnosis. Two patients did not undergo exploratory 
laparotomy because the diagnosis was established with a 
combination of characteristic clinical features and percu-
taneous needle liver biopsy. 
At the time of transplantation all 23 children (13 male 
[57% 1 and 10 female [43%» were jaundiced. with total bil-
irubin levels ranging from 84 to 958 ~mol/i (mean value, 
455 ~mol/rI 12 (52%) had ascites, and seven (30o/rl had a 
history of variceal bleeding, In 11 patients (48%) recent 
liver histologic features were diagnostic of cirrhosis, 
whereas the remaining 12 patients (52%) were found to 
have bridging fibrosis. The histopathologic evaluation of 
the hepatectomy specimens revealed severe cholestasis in 
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all 23 patients and established cirrhosis in 11 patients 
(48%). No malignancy was identified in any patient. 
Ages of the patients at the time of transplantation ranged 
from 6 months to 17.5 years, with a mean age of 5.0 years. 
Patients who had previously undergone a Kasai procedure 
had a mean age of 3.8 years at transplantation (range, 2 
months to 6.5 years), whereas the non-Kasai group (n=13) 
had a mean age of 6.2 years (range, 2 to 17.5 years). 
Postoperative Course 
With follow-up ranging from 2 to 9 years (mean follow-
up, 4.4 years), 13 (57%) of 23 patients receiving transplants 
are alive to date. Overall mortality (43.5%) was higher than 
in the contemporaneous general population of pediatric 
liver transplant recipients EPRKS%FK~T Four patients (17.4%) 
died of hepatic artery thrombosis, one (4.3%) of portal vein 
thrombosis, three (13%) of cardiovascular complications, 
one (4.3%) of an opportunistic infection, and one (4.3%) of 
primary graft nonfunction. Tables 2 and 3 summarize the 
relationship of the clinical characteristics of these patients 
to outcome after liver transplantation. Sepsis was the ter-
minal cause of death in six patients (26%). 
Eight children (35%) required retransplantation. One 
received three grafts and was alive 4 years later. The over-
all mortality after retransplantation was 75% (six of eight 
patients died). The cause of graft failure was hepatic artery 
thrombosis in eight cases, viral hepatitis in two cases, por-
tal vein thrombosis in one case, and rejection in one case. 
The 13 surviving children are to date free of jaundice and 
clinical or laboratory findings of liver failure. 
Table 1.-findings in 23 Patients Underg&fpg Liver 
Transplantation for Alagille's Syndrome 
No. (%) of Patients 
Finding (N=23) 
Intrahepatic bile duct paucity and 
cholestasis 23 (100) 
Cardiovascular anomalies with 
pulmonary artery stenosis as the 
main component 23 (100) 
Dvsmorphic facies 15 (65) 
Psychomotor retardation 14 (61) 
Skeletal malformations 11 (48)-
Ocular abnormalities (posterior 
embryotoxon) 10 (43.5) 
Xanthomas 6 (26) 
COMMENT 
Watson-Alagille syndrome is reportedly accompanied 
bv liver cirrhosis in 12% to 14% of cases.8.9 The downhill 
course is usually slow, allowing for proper evaluation and 
timely transplantation in these children, if n~edK ~KPKfl In-
dications for transplantation include impending liver fail-
ure, usually manifested by rapidly deepening jaundice and 
portal hypertension, particularly if complicated by severe 
bleeding or hypersplenism or ascites nonresponsive to 
conservative treatment. Nonfatal complications, such as 
failure to thrive or severe itching, may compromise the 
child's life enough to prompt transplantation. 
Our study was limited to the experience from the 
cyclosporine era to provide a homogeneous group with 
follow-up of more than 2 years. 
Skepticism on the eligibility of these patients for liver 
transplantation is mainly focused on the increased peri-
operative risk due to associated cardiopulmonary abnor-
malities. Our study demonstrates that, in fact, patients 
with cardiopulmonary anomalies are at increased risk af-
ter liver transplantation compared with average controls. 
Three of the deaths were due to heart failure secondary to 
preexisting cardiopulmonary disease. Other factors pre-
Table 2.-Patients' Clinical Characteristics as 
Determinants of Mortality 
No. ('¥o) of No. of 
Patients Deaths (% 
Characteristic (N=23) of Patients) 
Age, y 
<5 14 (61) 8 (57) 
~R 9 (39) 2 (22) 
• Body weight, kg 
<13 17 (74) 9 (53) 
~1P 6 (26) 1 (17) 
Total preoperative bilirubin 
level, ILmoVL 
<257 9 (39) 3 (33) 
~ORT 14 (61) 7 (50) 
Portal hypertension 12 (52) 6 (50) 
Without portal hypertension (I (48) 41361 
Previous Kasai procedure 10 (431 7 (70) 
Without previous Kasai 
procedure 13 (57) 3 (23) 
Peripheral pulmonary artery 
stenosis only 17 (74) i (41) 
Multiple cardiopulmonary 
anomalies 6 (26) J ISO) 
Table 3.-Cardiovascular Anomalies as Determinants of Mortality 
No. of Patients No. of Patients With No. of Patients 
With Mild Disease/ Moderate With Severe No. of Deaths due 
Type of Cardiovascular No. ("0) of Patients Disease/No. ('¥o) of Disease/No. (%) to Cardiac 
Anomalies Who Died Patients Who Died of Patients Who Died Complications 
Peripheral pulmonary artery stenosis 
only 9/2 (22) 8/5 (62) 0 p 
Peripheral pulmonary artery stenosis and 
other cardiac defectst 3/1 (33) 1/0 212 (100) 2* 
'Thls pallent had moderale disease. 
tCardiac defects included pulmonary valve stenosis in four patients; alrial septal defects in three patients; and pulmonary venous stenosis. bicus-
pid aortic valve, and coarctations of the aorta in one patient each. 
*Both of these patients had severe disease. 
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disposing to increased mortality in our series included 
previous portoenterostomy, young age, low weight, 
and high bilirubin levels; due to the small sample size, 
however, none of these factors achieved statistical 
significance. 
References 
1. Alagille D. Odievre M. Gautier M. Dommergues J. HepatiC ductular 
hypoplasia associated with characteristic facies. vertebral malformations. re-
tarded physical. mental and sexual developments. and cardiac murmur. 
J Pediatr. 1975;86:63-71. 
2. Alagille D. Estrada A. Hadchouel M. Gautier M. Odievre M. Dom-
mergues JP. Syndrome paucity of intralobular bile ducts IAlagilie syndrome 
or arteriohepatic dysplasia): review of 10 cases. J Pediatr. 1987;110:195-200. 
3. Alagille D. Management of paucity of interlobular bile ducts. J Hepa-
to/. 1985;1 :561-565. 
The value of thorough cardiopulmonary evaluation 
cannot be overemphasized. Preoperative cardiac Dop-
pler examinations should be performed routinely. Car-
diac catheterization should be performed if the results 
of the Doppler study are not conclusive. Patients with 
severe cardiopulmonary abnormalities tolerate the anhe-
patic phase of the transplantation better with the use of 
extracorporeal venovenous bypass. If this is not feasible, 
the use of the piggyback techniquel1 combined with a 
temporary portacaval shunt, as recently suggested, may 
alleviate the hemodynamic changes and assist in better 
survival. I:! 
4. Esquivel CO. Iwatsuki S. Gordon RD. et al.lndications for pediatric liv-
er transplantation. J Pediatr. 1987;111 :1039-1045. 
5. Esquivel CO. Vincente E. Van Thiel DH. et al. Orthotopic liver trans-
plantation for alpha-I-antitrypsin deficiency: an experience in 29 children 
and 10 adults. Transplant Proe. 1987;19:3798-3802. 
6. Tzakis AG. Starzl TE. Pediatric liver transplantation. In: Ashcraft KW. 
Holder TM. eds. Pediatric Surgery. 2nd ed. Phildelphia. Pa: WB Saunders Co. 
In press. 
7. Starzl TE. Iwatsuki S. Van Thiel DH. et al. Evolution of liver transplan-
tation. Hepatology. 1982;2 :614-636. 
8. Alagille D. Odievre M. Liver and Biliary Tract Disease in Children. New 
York. NY: Wiley-Flammarion Publishers; 1979. 
Heart, lung, and liver transplantation may be the only 
solution for patients with end-stage disease who are 
deemed incapable of receiving transplants due to the 
severity of the underlying cardiac disease. 
9. Perrault J. Paucity of interlobular bile ducts: getting to know it better. 
Dig Dis Sci. 1981;26:481-484. 
.10. oie~yK C~K Familial intrahepatic cholestatic syndromes. Semin Liver 
Drs. 1987.7.1 [9-133. 
11. Tzakis A. Todo S. Starzl TE. Orthotopic liver transplantation with 
preservation of the inferior vena cava. Ann Surg. 1989;210:649-652. 
This studv was supported in part bv research grants from the Vet-
erans Affairs Medical Center. Pittsburgh, Pa, and by project grant DK 
29961 from the National Institutes of Health, Bethesda, Md. 
12. Tzakis AG. Reyes I. Nour B. Marino IR. Todo S. Starzl TE. Temporary 
end-ta-slde ponocaval shunt in onhotoplC liver transplantation In humans. 
", Surg Gynecol Obstet. In press. 
I 
In Other AMA Journals • 
.., 
ARCHIVES OF PATHOLOGY & LABORATORY 
MEDICINE 
Peripheral Primitive Neuroectodermal Tumors: A Flow Cytometric 
Analysis With Immunohistochemical and Ultrastructural Observations 
Paul E. Swanson, MD; Waclaw ]aszcz, MD, PhD; 
Raouf E. Nakhleh, MD; David R. Kelly, MD; Louis P. Dehner, MD 
Flow cytometry of classical neuroblastoma has provided provocative evidence that 
cell cycle and ploidy analysis generate prognosticaIIy useful information. To deter-
mine whether such analyses of peripheral primitive neuroectodermal tumors might 
yield similar results, formalin-fixed, paraffin-embedded tissue specimens from 19 
peripheral primitive neuroectodermal tumors, each previously characterized by 
immunohistochemical or ultrastructural study. were assessed. An acceptable histo-
gram was obtained in 16 cases. Of these. nine neoplasms were diploid and seven 
contained aneuploid DNA. Among patients with diploid lesions. four were free of 
disease, whereas three had persistent or recurrent disease, and two had died of tu-
mor. Among patients with aneuploid neoplasms. four were free of disease, one had 
recurrence. and two had died. There was no apparent correlation between immu-
nophenotype and proliferative activity with the clinical outcome. Among aneuploid 
peripheral primitive neuroectodermal tumors, DNA index did not predict survivaL 
Hence. cell cycle and DNA ploidy analvses do not appear to contribute to the prog-
nostic assessment of peripheral primitive neuroectodermal tumors. as they do to 
presumably related neoplasms ot the central and peripheral nervous system (Arch 
Pat/IOI Lab Mcd. 1992;116:1202-1208). 
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